Loading

Does Tirzepatide Cause Hair Loss? Separating Fact from Clinical Data


Does Tirzepatide Cause Hair Loss? Separating Fact from Clinical Data
12/21/2025

Author: Dr. Sergey Terushkin, MD, FACS
Last Updated: March 23, 2026

Hair falling out after starting tirzepatide? You’re not alone—and it’s not what most people think. New clinical data shows that up to 5% of patients on Zepbound report hair shedding, but the real trigger isn’t the medication itself. It’s the rapid weight loss your body is going through. This temporary condition, known as telogen effluvium, can happen when fat loss outpaces nutritional balance. The good news: it’s reversible, manageable, and often preventable with the right medical guidance.

Key Takeaways

  • 🟢 Clinical Trial Data: Hair loss was reported by 4-5% of Zepbound users in clinical trials versus 1% on placebo, but the risk was highest in those with rapid, significant weight loss.
  • 🟢 Tirzepatide is NOT the direct cause. Hair shedding is overwhelmingly linked to the physical stress of rapid weight loss, a temporary condition called Telogen Effluvium (TE).
  • 🟢 Nutritional Priority: We monitor key nutrients, including Protein, Iron, Zinc, and Vitamins D and B12, as deficiencies can exacerbate shedding when calorie intake is restricted.
  • 🟢 Gender/Hormonal Link: The incidence was notably higher in women (~7%), suggesting that weight-loss-induced hormonal shifts may play a role.
  • 🟢 It is Reversible: Shedding is temporary and typically resolves on its own within 6–12 months once weight stabilizes.


Does GLP-1 Tirzepatide Affect Hair Growth? Examining the Science

Led by Dr. Sergey Terushkin, a board-certified, fellowship-trained surgeon specializing in sustained weight management at Florida Surgery And Weight Loss Center , we celebrate incredible patient transformations with medications such as Tirzepatide (Zepbound/Mounjaro). As the pounds drop quickly, however, a common question arises: “Does Tirzepatide cause hair loss?”

The answer is based on clinical evidence and our experience: The medication itself is not the primary cause. The hair shedding observed in some patients is strongly linked to the rapid rate of weight loss that Tirzepatide facilitates. This phenomenon is temporary and manageable, and we are here to help you understand why it happens and how to prevent it.


Woman noticing hair loss while holding a hairbrush, with medical infographic explaining tirzepatide, rapid weight loss, and hair shedding factors.

The True Cause: Tirzepatide, Weight Loss, and Telogen Effluvium

The vast majority of hair loss experienced during periods of rapid weight change is due to a condition called Telogen Effluvium (TE).

What the Clinical Data Reveals

In clinical trials for Zepbound (Tirzepatide), hair loss was reported in approximately 4% to 5% of individuals taking the medication, compared with 1% in the placebo group. This rate is higher than placebo, but key research findings suggest the following:

  • The Weight Loss Link: The highest rate of hair loss was observed in individuals who achieved the most significant weight reduction (over 20% of total body weight in a short period), which supports the conclusion that the rate of loss is the underlying trigger, not the medication’s chemistry.
  • Gender Disparity: The incidence was reported to be significantly higher in women (up to 7.1%) than in men (less than 1%), suggesting that hormonal shifts during rapid weight loss may contribute.

The Hair Cycle Disruption

TE is a temporary form of hair loss triggered by a significant physical stressor, such as rapid weight loss. When the body interprets this rapid change as a shock, it shifts energy away from non-essential functions, such as hair growth.

This forces a large number of growing hair follicles to enter the resting (Telogen) phase prematurely. The result is noticeable shedding about 2–4 months later, which can seem severe because a considerable amount of hair is falling out at once.


How Nutritional Deficiencies Impact Hair Health on Mounjaro/Zepbound

While TE is the primary mechanical cause, nutrient deficiencies often compound the problem, mainly when calorie intake is restricted.

Tirzepatide works by powerfully reducing appetite and increasing satiety, which is excellent for caloric deficit but can make it challenging to consume adequate micronutrients. If your diet is restrictive, you can develop deficiencies that weaken the hair follicle:

Key Nutrient for Hair HealthWhy It Matters
ProteinHair is almost entirely protein (keratin). Low intake directly impacts hair structure and growth. (We aim for 70-100 grams daily.)
Iron/FerritinLow iron stores are a major cause of hair loss, particularly in women.
Vitamin D & B12Vitamins D and B12 (along with Biotin) are critical for hair tissue growth, repair, and overall cellular function.
ZincDeficiency in this mineral is common with restrictive diets and can lead to weakened hair follicles.

At Florida Weight Loss MD, our medical supervision includes regular lab monitoring and a structured nutritional plan to ensure your health—and your hair—are protected.


How can you prevent hair loss during GLP-1 weight loss

How to Prevent Hair Loss During GLP-1 Weight Loss

A medical step-by-step approach to preventing hair loss during GLP-1 weight loss (semaglutide, tirzepatide), focusing on safe weight loss rate, protein intake, nutritional support, and early medical evaluation.

Step 1: Maintain a Safe Rate of Weight Loss

Rapid weight loss is the most common trigger of telogen effluvium (temporary hair shedding). A controlled, sustainable rate—typically around 1–2 pounds per week after the initial phase—helps reduce physiological stress and lowers the risk of hair loss.


Step 2: Prioritize Daily Protein Intake

Adequate protein is essential for hair growth and preservation. Most patients should aim for approximately 70–100 grams of lean protein daily, depending on body composition and medical guidance, to support both hair follicles and muscle mass.


Step 3: Correct Nutritional Deficiencies Early

Hair shedding during weight loss is often linked to deficiencies. Based on medical evaluation and lab work, targeted supplementation may include Iron, Zinc, Biotin, and Vitamins D and B12 to support healthy hair growth.


Step 4: Monitor Your Body’s Response Closely

Regular follow-up helps detect early signs of excessive shedding. Adjustments to nutrition, supplementation, or weight-loss pace can be made to reduce ongoing hair loss.


Step 5: Seek Dermatological Evaluation if Needed

If hair shedding is severe, prolonged, or atypical, consult a dermatologist to rule out underlying conditions such as thyroid dysfunction or alopecia areata.

Hair loss during GLP-1 weight loss is usually temporary and manageable when addressed early with proper medical guidance.

before and after banner - medical weight loss

GLP-1 weight loss programs at Florida Surgery & Weight Loss Center are provided by licensed medical professionals through secure telehealth visits across Florida.


Frequently Asked Questions (FAQ)


The Good News: Your Transformation is Worth It

The results of Tirzepatide are overwhelmingly positive and life-changing. Don’t let the fear of temporary hair shedding prevent you from achieving the profound health benefits of your weight loss goals.

At Florida Weight Loss MD, we provide the medical supervision, nutritional expertise, and lab monitoring necessary to manage this—and every other aspect—of your weight loss journey.

Schedule your confidential consultation with our medical team today to start your Tirzepatide program with confidence.



Medical References (Hair Loss & GLP-1 Weight Loss)

NIH / NCBI Review:
https://www.ncbi.nlm.nih.gov/books/NBK430848/
PubMed Clinical Data:
https://pubmed.ncbi.nlm.nih.gov/29090387/
Tirzepatide (NEJM):
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Useful Links:


Disclaimer:

GLP-1 medications, including Mounjaro® (Tirzepatide) and Semaglutide, require a medical evaluation and are not suitable for everyone. Side effects may occur, and results vary. Patients with certain medical conditions, including MEN2, medullary thyroid carcinoma, or pregnancy, may not be eligible. All prescriptions are provided by licensed U.S. clinicians and dispensed through regulated pharmacies. This content is for informational purposes only and not medical advice.



Skip to content